M&A Deal Summary

Audax Private Equity Acquires CW Advisors

On April 28, 2023, private equity firm Audax Private Equity acquired financial services company CW Advisors

Acquisition Highlights
  • This is Audax Private Equity’s 4th transaction in the Financial Services sector.
  • This is Audax Private Equity’s 155th transaction in the United States.
  • This is Audax Private Equity’s 13th transaction in Massachusetts.

M&A Deal Summary

Date 2023-04-28
Target CW Advisors
Sector Financial Services
Buyer(s) Audax Private Equity
Deal Type Recapitalization

Target

CW Advisors

Boston, Massachusetts, United States
CW Advisors is an independent registered investment advisor (“RIA”) offering wealth management and investment advisory services to high-net-worth individuals and families in the United States. CW Advisors was founded in 2009 and is based in Boston, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Audax Private Equity

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 19.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Audax Private Equity is a private equity firm focused on acquiring control positions in a variety of mid to large North American headquartered companies. The Firm segments its activities into lower middle-market and larger scale investing. Within its larger group, Audax targets profitable businesses valued up to $800 million and within its lower middle-market group, the Firm seeks companies valued up to $125 million. Sectors of interest include business services, consumer products/services, financial services, healthcare services, industrial services, software, and technology. Audax has a special interest in businesses that can benefit from a buy and build investment strategy for growth. Audax Private Equity was formed in 1999 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 163 of 167
Sector (Financial Services) 4 of 4
Type (Recapitalization) 15 of 15
State (Massachusetts) 13 of 13
Country (United States) 155 of 158
Year (2023) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-18 Pyramid Laboratories

Costa Mesa, California, United States

Pyramid Laboratories is a drug-product contract development and manufacturing organization (CDMO) that provides formulation development, analytical and stability testing, and aseptic fill-finish manufacturing services focused on large-molecule therapeutics. Pyramid Laboratories was founded in 1988 and is based in Costa Mesa, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-06 CorEvitas

Waltham, Massachusetts, United States

CorEvitas provides real-world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. Corona operates six major autoimmune registries across the US, Canada, and Japan, collecting data from over 500 participating investigator sites. CorEvitas was founded in 2001 and is based in Waltham, Massachusetts.

Sell $913M